Table 4. Odds of use of DED treatments among women versus men with DED.
OR (95% CI)* | P value* | |
---|---|---|
Level 1 | ||
Artificial tear use | 3.46 (2.71-4.41) | <0.0001 |
Lubricating eye ointment | 1.80 (1.33-2.43) | 0.0001 |
Hot compresses | 1.48 (1.07-2.04) | 0.02 |
Lid scrubs | 1.30 (0.90-1.88) | 0.16 |
Humidifier | 2.47 (1.59-3.83) | <0.0001 |
Eye washes | 1.01 (0.64-1.59) | 0.96 |
Cold compresses | 2.91 (1.58-5.37) | 0.0006 |
Moisture spray/mist | 8.11 (1.07-61.24) | 0.04 |
Level 2 and higher | ||
Omega-3 fatty acids | 1.74 (1.27-2.39) | 0.0006 |
Punctum plugs | 1.55 (1.11-2.16) | 0.01 |
Restasis® (cyclosporine eye drops) | 2.17 (1.48-3.17) | <0.0001 |
Steroid eye drops | 1.35 (0.68-2.67) | 0.39 |
Surgery/laser for permanent punctal occlusion | 1.57 (1.15-2.14) | 0.005 |
Oral antibiotics | 0.71 (0.34-1.49) | 0.36 |
Erythromycin eye ointment | 1.39 (0.60-3.22) | 0.45 |
Moisture or "airlock" goggles | 2.23 (0.46-10.68) | 0.32 |
The odds ratios (OR) indicate the ratio of women’s odds over men’s, each estimated from a separate logistic regression model adjusted for age.